Last reviewed · How we verify
C16G2 Strip
At a glance
| Generic name | C16G2 Strip |
|---|---|
| Sponsor | Armata Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application (PHASE2)
- A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- C16G2 Strip CI brief — competitive landscape report
- C16G2 Strip updates RSS · CI watch RSS
- Armata Pharmaceuticals, Inc. portfolio CI